SCHEMBL14412253

SCHEMBL14412253

NS(=O)(=O)N1CCC(Nc2nc(NCc3ccccc3Sc3ccccc3CO)nc3ccccc23)CC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 3/20 0.45
▸ WHR1 P49842 1/20 0.43
▸ EHMT2 Q96KQ7 2/20 0.42
▸ KDM1A O60341 1/20 0.42
▸ APP P05067 3/20 0.41
▸ BCHE P06276 2/20 0.41
▸ ACHE P22303 2/20 0.41
▸ MERTK Q12866 5/20 0.41
▸ DNMT3A Q9Y6K1 1/20 0.41
▸ LMNA P02545 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ NTSR1 P30989 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ NSD2 O96028 1/20 0.38
▸ NPY5R Q15761 2/20 0.37
▸ CXCR4 P61073 1/20 0.37
▸ TLR7 Q9NYK1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14256741 0.92 WHR1 (0.45) PDE5AWHR1EHMT2KDM1AAPP
SCHEMBL14256444 0.86 MERTK (0.53) PDE5AWHR1APPBCHEACHE
SCHEMBL14256699 0.85 MERTK (0.52) PDE5AAPPBCHEACHEMERTK
SCHEMBL14256734 0.84 EHMT2 (0.47) PDE5AWHR1EHMT2KDM1AAPP
SCHEMBL14412248 0.84 APP (0.45) WHR1EHMT2KDM1AAPPBCHE
SCHEMBL14256700 0.83 APP (0.46) WHR1EHMT2KDM1AAPPBCHE
SCHEMBL14412272 0.83 CXCR4 (0.52) WHR1APPBCHEACHEMERTK
SCHEMBL14412234 0.83 GBA1 (0.49) APPBCHEACHEMERTKLMNA
SCHEMBL14412273 0.81 EHMT2 (0.44) WHR1EHMT2KDM1AAPPBCHE
SCHEMBL14256736 0.81 DNMT3A (0.53) WHR1EHMT2KDM1AACHEMERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070213319-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2007-09-13 — — US disclosed
US-20070213319-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2007-09-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213319-A1 Modulators of hepatocyte growth factor/c-Met activity HGF, MET, HDGF PDE5A 2957/4885WHR1 2846/4885EHMT2 1276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback